Key facts

Active Substance
  • procaine (hydrochloride)
  • xylitol
  • potassium chloride
  • magnesium sulfate heptahydrate
Therapeutic area
Other
Decision number
P/0295/2021
PIP number
EMEA-001171-PIP01-11-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Cardioplegia
Route(s) of administration
Intracoronary use
Contact for public enquiries

MIT Gesundheit GmbH

Switzerland
Tel. +41 763804835
E-mail: info@swisscardiotech.com

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page